JAMA SJR and Scopus Metrics: What the Numbers Actually Tell Authors
JAMA's Scopus profile is elite for general medicine, but the real submission question is whether the paper truly needs a broad clinical audience.
Associate Professor, Clinical Medicine & Public Health
Author context
Specializes in clinical and epidemiological research publishing, with direct experience preparing manuscripts for NEJM, JAMA, BMJ, and The Lancet.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Quick answer: JAMA remains an elite general-medicine journal under Scopus-style metrics. Current Scopus-linked browser data reports a 2024 SJR of 5.352, a CiteScore of 30.8, and top-tier placement in medicine. That confirms real flagship status, but the submission decision still depends more on whether the manuscript truly belongs in a broad general-medical room than on the metric itself.
The core metric picture
Metric | 2024 value | What it tells you |
|---|---|---|
SJR | 5.352 | Prestige-weighted influence is elite |
CiteScore | 30.8 | Four-year citation performance is very strong |
SNIP | 10.710 | Field-normalized impact remains high |
Rank | 8 / 668 in medicine | The journal sits firmly in the top medical tier |
JCR context | Impact factor 55.0 | Web of Science tells the same flagship story |
The useful reading is that JAMA still combines broad clinical visibility with a serious editorial filter. It is not at the absolute citation peak of NEJM or The Lancet, but it is clearly in the same flagship conversation.
What the metrics actually help with
They help explain where JAMA fits:
- clearly above ordinary high-end specialty journals on broad medical visibility
- strong enough that publication carries real institutional signal
- somewhat broader in editorial mix than some of the other top general-medical titles
That is useful when the shortlist includes JAMA, a top specialty journal, or another general-medicine flagship.
What the metrics do not answer
They do not tell you:
- whether the manuscript is broad enough across medicine
- whether the study changes clinical thinking outside one specialty
- whether the paper belongs in JAMA rather than a narrower field journal
- whether the clinical consequence is strong enough for a flagship route
Those are still the real editorial questions.
Why the profile matters for authors
At this SJR level, JAMA is buying authors:
- broad clinical readership
- strong institutional legibility
- room for important clinical, policy, and health-services papers
- a flagship brand that still matters to committees and coauthors
That is why the journal can be elite without looking identical to NEJM or The Lancet. The citation profile reflects a slightly different editorial mix, not a weak signal.
What should drive the submission decision instead
The better question is whether the manuscript is truly a JAMA paper.
That is why the better next reads are:
- Is JAMA a good journal?
- JAMA submission guide
- JAMA submission process
- JAMA acceptance rate
If the paper deserves broad clinical attention, the metrics support the choice. If it is mainly a specialty-facing paper, the same metrics are telling you why the general-medicine bar will stay hard.
Practical verdict
JAMA has elite Scopus-style metrics and remains a serious flagship destination. That makes it a rational target for clinically consequential work that deserves a wide medical audience.
But the useful takeaway is still fit, not comfort. If the manuscript is not truly broad enough, the numbers do not rescue the mismatch. A free Manusights scan is the fastest way to pressure-test that before submission.
- JAMA submission guide, Manusights.
Sources
- 1. JAMA journal browser entry, University of Twente.
- 2. JAMA journal page, JAMA Network.
- 3. JAMA instructions for authors, JAMA Network.
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.